USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
17.19
-0.64 (-3.59%)
Mar 9, 2026, 2:30 PM EDT - Market open

Company Description

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration.

It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online.

The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.

USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

USANA Health Sciences, Inc.
USANA Health Sciences logo
Country United States
Founded 1992
IPO Date Jul 25, 1996
Industry Packaged Foods
Sector Consumer Staples
Employees 1,700
CEO Kevin Guest

Contact Details

Address:
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
United States
Phone 801 954 7100
Website usana.com

Stock Details

Ticker Symbol USNA
Exchange NYSE
Stock Type Common Stock
Fiscal Year February - January
Reporting Currency USD
CIK Code 0000896264
CUSIP Number 90328M107
ISIN Number US90328M1071
Employer ID 87-0500306
SIC Code 2833

Key Executives

Name Position
Kevin G. Guest Chief Executive Officer and Executive Chairman
G. Douglas Hekking Chief Financial Officer
Walter Noot Chief Operating Officer
P. Joshua Foukas J.D. Chief Legal Officer, General Counsel and Corporate Secretary
Brent L. Neidig Chief Commercial Officer
Dr. Myron W. Wentz Ph.D. Founder and Chairman Emeritus
Dr. John Cuomo Executive Director of Product Development and Technology
Peter Benedict Chief Information Officer
Dr. Kathryn Armstrong Ph.D. Chief Scientific Officer
Patrique Richards Executive Director of Investor Relations and Business Development

Latest SEC Filings

Date Type Title
Mar 3, 2026 144 Filing
Feb 20, 2026 144 Filing
Feb 18, 2026 8-K Current Report
Feb 11, 2026 8-K/A [Amend] Current report
Jan 21, 2026 SCHEDULE 13G/A Filing
Jan 21, 2026 SCHEDULE 13G/A Filing
Jan 12, 2026 8-K Current Report
Jan 8, 2026 8-K Current Report
Dec 10, 2025 144 Filing
Nov 5, 2025 10-Q Quarterly Report